Steven G. Elliott - 01 Apr 2022 Form 4 Insider Report for PPL Corp (PPL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Apr 2022, 16:17:00 UTC
Prior SEC filing
04 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ W. Eric Marr, as Attorney-In-Fact for Steven G. Elliott

Key filing fact

Steven G. Elliott filed Form 4 for PPL Corp (PPL) on 04 Apr 2022.

Key facts

  • This page summarizes Steven G. Elliott's Form 4 filing for PPL Corp (PPL).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 04 Apr 2022, 16:17.

Change

  • Previous filing in this sequence was filed on 04 Jan 2022.
  • Current net transaction value: +$20,014.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PPL transaction Derivative

Stock Unit (DDCP)

Award

Transaction value
$20,014
Shares
+690
Change %
+1%
Price
$29.02
Shares after
67,361
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
690
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

No conversion or exercise price applies as, under the terms of the Directors Deferred Compensation Plan (DDCP), payout of the underlying securities will occur following a director's retirement.

Footnote F2

Total includes the reinvestment of dividends.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .